This 2019 report to the President and Congress describes how the U.S. Department of Health and Human Services plans to assist states in providing housing-related supports to individuals with substance use disorders in Medicaid as instructed by the 2018 SUPPORT Act. The report describes forthcoming initiatives from
This guide from the National Institute on Drug Abuse addresses treating opioid use disorder (OUD) during pregnancy. It includes information about the effects of OUD on unborn children and newborns and about the benefits of medication assisted treatment for pregnant women with OUD diagnoses.
This 2014 guideline from the Michigan Department of Community Health provides an overview of addiction and opioid use disorder with information specifically about medication assisted treatment.
This website includes links to 7 webinars that make up the Support for Hospital Opioid Use Treatment (Project SHOUT) initiative of the California Health Care Foundation. Topics covered in the webinar series include: the case for inpatient opioid agonist therapy; buprenorphine and methadone induction; acute pain and
This website provides training curricula, treatment provider guidelines and resources for providers and payers offering family-centered behavioral health support for pregnant and postpartum women. The website include a resource library with more than 300 documents, a section for highlighting innovative programs, and information about
This 2019 update on medications to treat opioid use disorder and opioid withdrawal provides information about extended release formulations of buprenorphine, reviews evidence for the effectiveness of lofexidene to treat withdrawal symptoms, and also includes a table with comparative costs of opioid use disorder pharmacological therapies.
This 2 page patient information guide provides information about the risks of taking common drugs or medications including opioids during pregnancy. Part of the Arizona ReThink RX Abuse initiative which helps communities educate their citizens about prescription drug safety.
This clinician’s guide from the California Health Care Foundation aims to provide primary care providers with “everything they need to know” about buprenorphine. It includes background information on buprenorphine’s effectiveness as a treatment for opioid use disorder and the Drug Addiction Treatment Act
This 2015 guide to naloxone for the treatment of opioid overdoses from The College of Psychiatric and Neurologic Pharmacists includes information about the various forms of naloxone, briefly describes state and local naloxone distribution efforts, and includes sample patient information sheets.
The Arizona Substance Abuse Task Force produced this 2016 report recommending policy changes to address the opioid crisis. Topics covered included identifying evidence based treatments, improving access to substance use disorder treatment, focusing on prevention and early